346 related articles for article (PubMed ID: 19067971)
21. Induction of microphthalmia transcription factor (Mitf) by forskolin and stimulation of melanin release in UISO-Mel-6 cells.
Lekmine F; Salti GI
J Surg Res; 2008 Sep; 149(1):27-30. PubMed ID: 18028952
[TBL] [Abstract][Full Text] [Related]
22. EMX homeobox genes regulate microphthalmia and alter melanocyte biology.
Bordogna W; Hudson JD; Buddle J; Bennett DC; Beach DH; Carnero A
Exp Cell Res; 2005 Nov; 311(1):27-38. PubMed ID: 16197942
[TBL] [Abstract][Full Text] [Related]
23. Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform.
Hershey CL; Fisher DE
Gene; 2005 Feb; 347(1):73-82. PubMed ID: 15715979
[TBL] [Abstract][Full Text] [Related]
24. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
[TBL] [Abstract][Full Text] [Related]
25. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
26. Specific expression of Gsta4 in mouse cochlear melanocytes: a novel role for hearing and melanocyte differentiation.
Uehara S; Izumi Y; Kubo Y; Wang CC; Mineta K; Ikeo K; Gojobori T; Tachibana M; Kikuchi T; Kobayashi T; Shibahara S; Taya C; Yonekawa H; Shiroishi T; Yamamoto H
Pigment Cell Melanoma Res; 2009 Feb; 22(1):111-9. PubMed ID: 18983533
[TBL] [Abstract][Full Text] [Related]
27. MITF pathway mutations in melanoma.
Yokoyama S; Salma N; Fisher DE
Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
[No Abstract] [Full Text] [Related]
28. Low expression of microphthalmia-associated transcription factor, a potential molecular target for interferon-alpha susceptibility, is associated with metastasis in renal cell carcinoma.
Shimazui T; Kojima T; Yoshikawa K; Ami Y; Oikawa T; Uchida K; Akaza H
Cancer Sci; 2009 Sep; 100(9):1714-8. PubMed ID: 19496784
[TBL] [Abstract][Full Text] [Related]
29. "Lineage addiction" in human cancer: lessons from integrated genomics.
Garraway LA; Weir BA; Zhao X; Widlund H; Beroukhim R; Berger A; Rimm D; Rubin MA; Fisher DE; Meyerson ML; Sellers WR
Cold Spring Harb Symp Quant Biol; 2005; 70():25-34. PubMed ID: 16869735
[TBL] [Abstract][Full Text] [Related]
30. MITF, the Janus transcription factor of melanoma.
Koludrovic D; Davidson I
Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
[TBL] [Abstract][Full Text] [Related]
31. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
[TBL] [Abstract][Full Text] [Related]
32. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
[TBL] [Abstract][Full Text] [Related]
34. Microphthalmia transcription factor isoforms in mast cells and the heart.
Tshori S; Sonnenblick A; Yannay-Cohen N; Kay G; Nechushtan H; Razin E
Mol Cell Biol; 2007 Jun; 27(11):3911-9. PubMed ID: 17438132
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R
Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743
[TBL] [Abstract][Full Text] [Related]
36. The three M's: melanoma, microphthalmia-associated transcription factor and microRNA.
Bell RE; Levy C
Pigment Cell Melanoma Res; 2011 Dec; 24(6):1088-106. PubMed ID: 22004179
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA regulation of melanoma progression.
Bonazzi VF; Stark MS; Hayward NK
Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
[TBL] [Abstract][Full Text] [Related]
38. From integrated genomics to tumor lineage dependency.
Garraway LA; Sellers WR
Cancer Res; 2006 Mar; 66(5):2506-8. PubMed ID: 16510564
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
Bertucci F; Pages C; Finetti P; Rochaix P; Lamant L; Devilard E; Nguyen C; Houlgatte R; Birnbaum D; Xerri L; Brousset P
Anticancer Res; 2007; 27(5A):3441-9. PubMed ID: 17970093
[TBL] [Abstract][Full Text] [Related]
40. A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells.
Yagil Z; Kay G; Nechushtan H; Razin E
J Immunol; 2009 Feb; 182(4):2168-75. PubMed ID: 19201870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
